--2024/Q4-- / 196.754M--
--2024/Q3-- / 194.791M--
Aug 7, 20242024/Q2182.394M / 170.910M--
May 8, 20242024/Q1171.800M / 174.713M--
Feb 28, 20242023/Q4178.105M / 173.326M--
US Stock MarketDetailed Quotes
AMPH Amphastar Pharmaceuticals
- 46.250
- +1.290+2.87%
Trading Aug 19 10:37 ET
2.25BMarket Cap14.68P/E (TTM)
46.310High45.010Low67.53KVolume45.010Open44.960Pre Close3.10MTurnover0.18%Turnover Ratio17.79P/E (Static)48.68MShares65.92552wk High3.16P/B1.75BFloat Cap36.56052wk Low--Dividend TTM37.79MShs Float67.660Historical High--Div YieldTTM2.89%Amplitude6.670Historical Low45.940Avg Price1Lot Size
Amphastar Pharmaceuticals Key Stats
Amphastar Pharmaceuticals Q2 2024 Earnings Date
Currency：USDAug 7, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 170.91M | 182.39M | +11.48M |
| Beat Est. | +17.29% | +25.17% | +6.72% |
| EPS | 0.81 | 0.73 | -0.08 |
| Miss Est. | +66.22% | +48.98% | -10.37% |
Analyst Rating
Aug 8, 2024
Amphastar Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Amphastar Pharmaceuticals Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
